Trikafta Exercise Study in Cystic Fibrosis

RecruitingOBSERVATIONAL

Enrollment

Participants

Timeline

Start Date

November 10, 2021

Primary Completion Date

December 31, 2025

Study Completion Date

December 31, 2025

Conditions

Cystic FibrosisLung Diseases

Interventions

DRUG

Trikafta

Elexacaftor/Tezacaftor/Ivacaftor combination therapy

Trial Locations (1)

RECRUITING

UBC Centre for Heart Lung Innovation, St. Paul's Hospital, Vancouver

All Listed Sponsors

lead

University of British Columbia

OTHER